Miral, Rosita O.

HRN: 24-11-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/27/2023
12/04/2023
IV
1.5
Q8
Cellulitis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: